𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prevention of the “no reflow” phenomenon in the canine heart by mioflazine

✍ Scribed by W. Flameng; R. Xhonneux; J. Vanhaecke; A. Van de Water; M. Suy

Publisher
Springer
Year
1985
Tongue
English
Weight
546 KB
Volume
80
Category
Article
ISSN
0300-8428

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intracoronary adenosine administered dur
Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of “no reflow” phenomenon
✍ Abid R. Assali; Stefano Sdringola; Mohammad Ghani; Ali E. Denkats; Armando Yepes 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB 👁 2 views

Percutaneous intervention in acute myocardial infarction has been associated with a high incidence of "no reflow," ranging from 11% to 30%, with an increased risk of complications. The role of intracoronary adenosine for the prevention of this phenomenon has not been evaluated fully. We studied the

Comparison of combination therapy of ade
Comparison of combination therapy of adenosine and nitroprusside with adenosine alone in the treatment of angiographic no-reflow phenomenon
✍ Cem Barcin; Ali E. Denktas; Ryan J. Lennon; LaVon Hammes; Stuart T. Higano; Davi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract We sought to compare the combination therapy of adenosine and nitroprusside in no‐reflow phenomenon during percutaneous coronary intervention. Improvement in coronary flow from no‐reflow to postdrug state was evaluated. Patients who received adenosine (n = 21) were compared to ones who